2019
Regional and Rural-Urban Differences in the Use of Direct-acting Antiviral Agents for Hepatitis C Virus
Njei B, Esserman D, Krishnan S, Ohl M, Tate JP, Hauser RG, Taddei T, Lim J, Justice AC. Regional and Rural-Urban Differences in the Use of Direct-acting Antiviral Agents for Hepatitis C Virus. Medical Care 2019, 57: 279-285. PMID: 30807449, PMCID: PMC6436819, DOI: 10.1097/mlr.0000000000001071.Peer-Reviewed Original ResearchConceptsDirect-acting antiviral agentsHepatitis C virus infectionVeterans Affairs Healthcare SystemRural-Urban Commuting Area codesCurative HCV treatmentRural-urban designationC virus infectionElectronic health record dataHepatitis C virusPrior treatment experienceLower odds ratioHealth record dataZone improvement plan codeEligible patientsHCV treatmentAntiretroviral medicationsRural-urban residenceLiver diseaseUnadjusted analysesC virusRural-urban differencesOdds ratioMultivariable modelLower incidenceObservational study
2018
Palliative care in decompensated cirrhosis: A review
Langberg KM, Kapo JM, Taddei TH. Palliative care in decompensated cirrhosis: A review. Liver International 2018, 38: 768-775. PMID: 29112338, DOI: 10.1111/liv.13620.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsPalliative carePatient populationProspective randomized control trialIncidence of cirrhosisPalliative care consultationAdvanced care planningPatient-reported outcomesSmall observational studiesPotential treatment optionCost of careRandomized control trialQuality of lifeLiver transplantSymptom controlICU utilizationLiver diseaseCare consultationsTreatment optionsPatient satisfactionHospital costsObservational studyCirrhosisCare planningControl trialOnly cure